EPCORITAMAB
UNII D6OMY2L0WA

Substance Identification & Data

This profile provides standardized clinical and technical data for Epcoritamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D6OMY2L0WA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2134641-34-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D6OMY2L0WA

CAS Registry Number

2134641-34-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EPCORITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

D6OMY2L0WA

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C163022

National Cancer Institute reference terminology for clinical and research data.

INN ID

11078

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-92

Identifier assigned by the United States Adopted Names Council.

Substance Type

EPCORITAMAB

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Epcoritamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EPCORITAMAB

Epcoritamab-BYSP

Common Names & Synonyms

EPCORITAMAB [USAN]

Epcoritamab [MI]

Epcoritamab [WHO-DD]

Epcoritamab bysp [WHO-DD]

Immunoglobulin G1 [234-phenylalanine, 235-glutamic acid, 265-alanine, 405-leucine], anti-(human CD3 antigen) (human-Mus musculus monoclonal IgG1-huCACAO-FEAL γ1-chain), disulfide with human-Mus musculus monoclonal IgG1-huCACAO-FEAL λ-chain, (234→231'),(237→234')-bis(disulfide) with immunoglobulin G1 [234-phenylalanine, 235-glutamic acid, 265-alanine, 409-arginine] anti-(human CD20 antigen) (human monoclonal IgG1-7D8-FEAR γ1-chain) disulfide with human monoclonal IgG1-7D8-FEAR κ-chain

Immunoglobulin G1-lambda/kappa, anti-[Homo sapiens CD3E (CD3 epsilon)] and anti-[Homo sapiens MS4A1 (membrane-spanning 4-domains subfamily A member 1, CD20)], monoclonal bispecific antibody; gamma1 heavy chain chimeric anti-CD3E (1-454) [VH (Mus musculus IGHV10-1*02 (93.9%) -(IGHD) -IGHJ3*01 (93.3%)/Homo sapiens IGHV3-72*01 (81.0%) -(IGHD) -IGHJ6*01 (67.0%)) [8.10.16] (1-125) -Homo sapiens IGHG1*03 G1m3, nG1m1 (CH1 R120 (222) (126-223), hinge 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), D27>A (273) (239-348), CH3 E12 (364), M14(366), F85.1>L (413) (349-453), CHS K2>del (454)) (126-454)], (228-214')-disulfide with lambda light chain chimeric (1'-215') [V-LAMBDA (Mus musculus IGLV1*01 (83.3%) -IGLJ1*01 (100%)/Homo sapiens IGLV8-61*01 (70.8%) - IGLJ3*02 (100%)) [9.3.9] (1'-109') -Homo sapiens IGLC2*01 (100%) (110'-215')]; gamma1 heavy chain Homo sapiens anti-MS4A1 (1''-451'') [VH (Homo sapiens IGHV3-9*01 (96.0%) -(IGHD) -IGHJ6*01 (100%)) [8.8.15] (1''-122'') -Homo sapiens IGHG1*03 G1m3, G1m1 (CH1 R120 (219) (123-220), hinge 1-15 (221-235), CH2 L1.3>F (239), L1.2>E (240), D27>A (270) (236-345), CH3 E12 (361), M14 (363), K88>R (414) (346-450), CHS K2>del (451)) (123''-451'')], (225''-214''')-disulfide with kappa light chain Homo sapiens (1'''-214''') [V-KAPPA (Homo sapiens IGKV3-11*01 (100%) -IGKJ5*01 (100%)) [6.3.9] (1'''-107''') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'''-214''')]; dimer (234-231'':237-234'')-bisdisulfide, produced in Chinese Hamster Ovary (CHO)-S cell line, glycoform alfa

epcoritamab [INN]